Cargando…
Serological and cellular inflammatory signatures in end‐stage kidney disease and latent tuberculosis
OBJECTIVES: Tuberculosis comorbidity with chronic diseases including diabetes, HIV and chronic kidney disease is of rising concern. In particular, latent tuberculosis infection (LTBI) comorbidity with end‐stage kidney disease (ESKD) is associated with up to 52.5‐fold increased risk of TB reactivatio...
Autores principales: | McLean, Milla R, Wragg, Kathleen M, Lopez, Ester, Kiazyk, Sandra A, Ball, Terry Blake, Bueti, Joe, Kent, Stephen J, Juno, Jennifer A, Chung, Amy W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569694/ https://www.ncbi.nlm.nih.gov/pubmed/34765193 http://dx.doi.org/10.1002/cti2.1355 |
Ejemplares similares
-
Mucosal-Associated Invariant T Cells Are Depleted and Exhibit Altered Chemokine Receptor Expression and Elevated Granulocyte Macrophage-Colony Stimulating Factor Production During End-Stage Renal Disease
por: Juno, Jennifer A., et al.
Publicado: (2018) -
An Inflammatory Story: Antibodies in Tuberculosis Comorbidities
por: McLean, Milla R., et al.
Publicado: (2019) -
The blood transcriptional signature for active and latent tuberculosis
por: Deng, Min, et al.
Publicado: (2019) -
SARS‐CoV‐2‐specific CD8(+) T‐cell responses and TCR signatures in the context of a prominent HLA‐A*24:02 allomorph
por: Rowntree, Louise C, et al.
Publicado: (2021) -
Anatomic and Cellular Niches for Mycobacterium tuberculosis in Latent Tuberculosis Infection
por: Mayito, Jonathan, et al.
Publicado: (2019)